CRIS Current Research Information System

GIORDANI, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.616
EU - Europa 3.881
NA - Nord America 3.701
AF - Africa 328
SA - Sud America 218
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.761
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.619
IT - Italia 1.638
CN - Cina 1.282
SG - Singapore 1.217
VN - Vietnam 1.018
GB - Regno Unito 582
DE - Germania 400
HK - Hong Kong 382
SE - Svezia 240
IN - India 205
FR - Francia 201
BR - Brasile 165
NL - Olanda 160
KR - Corea 154
RU - Federazione Russa 143
CI - Costa d'Avorio 102
IE - Irlanda 98
FI - Finlandia 92
UA - Ucraina 72
ZA - Sudafrica 70
JP - Giappone 67
TG - Togo 59
CA - Canada 47
ID - Indonesia 43
CH - Svizzera 37
SC - Seychelles 35
BE - Belgio 34
TH - Thailandia 32
EE - Estonia 31
JO - Giordania 28
AR - Argentina 26
BG - Bulgaria 26
ES - Italia 23
PH - Filippine 22
TR - Turchia 22
NG - Nigeria 21
IQ - Iraq 19
IR - Iran 18
PK - Pakistan 18
PL - Polonia 18
AT - Austria 17
BD - Bangladesh 16
MX - Messico 16
TW - Taiwan 15
AU - Australia 12
MY - Malesia 11
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
GR - Grecia 9
HR - Croazia 9
NO - Norvegia 9
EC - Ecuador 8
EG - Egitto 8
TN - Tunisia 8
CL - Cile 7
RO - Romania 6
SA - Arabia Saudita 6
DK - Danimarca 5
DZ - Algeria 5
IL - Israele 5
KE - Kenya 5
LB - Libano 5
BB - Barbados 4
CO - Colombia 4
MA - Marocco 4
NZ - Nuova Zelanda 4
OM - Oman 4
SI - Slovenia 4
AL - Albania 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
KZ - Kazakistan 3
SN - Senegal 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
ET - Etiopia 2
KW - Kuwait 2
LT - Lituania 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CU - Cuba 1
CV - Capo Verde 1
EU - Europa 1
GH - Ghana 1
GL - Groenlandia 1
Totale 12.751
Salva come PNG Salva come JPEG
Città #
Singapore 824
Southend 465
Ashburn 435
Hong Kong 349
Bologna 311
Hefei 302
San Jose 252
Chandler 245
Ho Chi Minh City 223
Hanoi 221
Ann Arbor 167
Santa Clara 157
Seoul 141
Dallas 127
Beijing 126
Frankfurt am Main 126
Los Angeles 118
Fairfield 117
Abidjan 102
Princeton 102
Boardman 98
Dong Ket 97
Dublin 95
Milan 89
Wilmington 82
Seattle 78
Council Bluffs 77
Houston 75
New York 74
Helsinki 64
Lauterbourg 64
Rome 62
Lomé 59
Cambridge 52
Turin 52
Woodbridge 52
Nanjing 49
Padova 48
Tokyo 47
Berlin 42
Redmond 42
Westminster 42
Shanghai 41
Guangzhou 40
Medford 33
Buffalo 32
Dearborn 32
Tukwila 32
Haiphong 30
Bengaluru 29
Da Nang 29
Munich 29
Amman 28
Jinan 28
Redondo Beach 25
Sofia 25
Basingstoke 24
Jakarta 24
Naples 24
Tianjin 24
Shenyang 22
Abeokuta 21
Brussels 21
Chicago 21
Florence 21
Bern 20
Johannesburg 20
São Paulo 20
The Dalles 20
Montreal 19
Nanchang 19
Redwood City 19
Changsha 18
Toronto 18
London 17
Saint Petersburg 17
Cesena 16
Modena 16
Orem 16
Zhengzhou 16
Biên Hòa 15
Catania 15
Genoa 15
Verona 15
Amsterdam 14
Bangkok 14
Forlì 14
Lappeenranta 14
Cagliari 12
Des Moines 12
Hebei 12
Atlanta 11
Boston 11
Brooklyn 11
Falkenstein 11
Nuremberg 11
Xi'an 11
Boydton 10
Hangzhou 10
Hyderabad 10
Totale 7.504
Salva come PNG Salva come JPEG
Nome #
Accuratezza della spettrometria di massa MALDI-TOF nell’identificazione di specie di lattobacilli 714
NUOVI APPROCCI PER L’IDENTIFICAZIONE DI SPECIE DI LATTOBACILLI: RUOLO DELLA SPETTROMETRIA DI MASSA MALDI-TOF E DELLA METABOLOMICA 484
BIFIDOBACTERIUM BREVE BC104: ORALLY ADMINISTERED VAGINAL PROBIOTIC FOR PREVENTING GENITAL AND URINARY TRACT INFECTIONS 337
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 283
Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis 280
Antioxidant and Functional Features of Pre-Fermented Ingredients Obtained by the Fermentation of Milling By-Products 254
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion 239
Design and validation of a DNA-microarray for phylogenetic analysis of bacterial communities in different oral samples and dental implants 221
Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models 216
Anti-bacterial activity of vaginal lactobacilli against Chlamydia trachomatis 207
Biosurfactant for solubilization and skin permeation enhancement of hydrocortisone 207
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 207
Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms 206
Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis 205
Biotechnological Valorization of Brewer's Spent Grains and Grape Pomace to Obtain Functional Ingredients for Food Formulations 197
Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 197
Novel mixed vesicles containing lactobacilli biosurfactants for vaginal delivery of econazole nitrate 197
OralArray: a new phylogenetic DNA-microarray to characterize the oral microbiota 195
Vaginal Lactobacillus strains interfere with Chlamydia trachomatis infection 186
Lactobacilli cell-free supernatants: Potential green and natural enhancers for nose-to-brain delivery of small hydrophilic molecules 183
Vaginal Lactobacillus Impair Candida Dimorphic Switching and Biofilm Formation 179
Association of mucoadhesive polymeric matrices and liposomes for local delivery of miconazole: A new approach for the treatment of oral candidiasis 175
Lecithin and Chitosan as Building Blocks in Anti-Candida Clotrimazole Nanoparticles 170
Studio in vitro dell’attività antimicrobica di lattobacilli vaginali nei confronti di Chlamydia trachomatis. 170
Dairy bioactives and functional ingredients with skin health benefits 169
Vaginal Lactobacillus gasseri biosurfactant: a novel bio- and eco-compatible anti-Candida agent 168
Limosilactobacillus vaginalis Exerts Bifidogenic Effects: A Novel Postbiotic Strategy for Infant Prebiotic Supplementation 166
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections 166
Approcci innovativi per l’identificazione di specie di lattobacilli: studio dei metaboliti mediante spettrometria di risonanza magnetica (1H-RMN) 165
Isolation and characterization of biosurfactants produced by Lactobacillus gasseri of vaginal origin 163
Biosurfactant loaded vesicles for the local treatment of Staphylococcus aureus skin infections 163
Anti-candida activity of hyaluronic acid combined with lactobacillus crispatus lyophilised supernatant: A new antifungal strategy 157
Mucoadhesive and mucopenetrating chitosan nanoparticles for glycopeptide antibiotic administration 154
Orange Peel Lactiplantibacillus plantarum: Development of A Mucoadhesive Nasal Spray with Antimicrobial and Anti-Inflammatory Activity 154
Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets 151
Functional and biochemical characterization of pre-fermented ingredients obtained by the fermentation of durum wheat by-products 147
Ondansetron Buccal Administration for Paediatric Use: A Comparison Between Films and Wafers 147
Development and validation of a new phylogenetic DNA-microarray specific for the oral microbiota 144
Lactobacillus crispatus BC1 Biosurfactant Delivered by Hyalurosomes: An Advanced Strategy to Counteract Candida Biofilm 144
Freeze-Dried Matrices Based on Polyanion Polymers for Chlorhexidine Local Release in the Buccal and Vaginal Cavities 143
Interaction of vaginal Lactobacillus strains with HeLa cell plasma membrane. 142
THE HEALTH-PROMOTING EFFECT OF EXTRACELLULAR VESICLES RELEASED BY VAGINAL LACTOBACILLI 140
Prebiotic Activity of Vaginal Lactobacilli on Bifidobacteria: from Concept to Formulation 139
Lactobacillus strains isolated from vaginal microbiota of healthy women inhibit Candida growth and adherence 135
The vaginal microbiome of healthy, bacterial vaginosis and Chlamydia trachomatis-infected women 135
Role of vaginal lactobacilli in counteracting Chlamydia trachomatis infectivity in an in vitro model 134
Effect of Lactobacillus biosurfactant on hydrocortisone solubilization and skin permeation 134
Utilizing liposomal quercetin and gallic acid in localized treatment of vaginal Candida infections 134
Novel approaches for the species-level identification of lactobacilli: integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 132
New Spanish Broom dressings based on Vitamin E and Lactobacillus plantarum for superficial skin wounds 132
Lactobacillus crispatus BC1 Biosurfactant Counteracts the Infectivity of Chlamydia trachomatis Elementary Bodies 129
Influence of lactobacillus biosurfactants on skin permeation of hydrocortisone 127
Lactobacilli cell-free supernatants can improve cromolyn nasal absorption 125
Characterization of anti-Candida activity of vaginal lactobacilli 124
Biosurfactant-based mixed vesicles for vaginal delivery of econazole 123
Lactobacillus Biofilms Influence Anti-Candida Activity 118
Interaction of vaginal Lactobacillus strains with HeLa cells plasma membrane 117
Preliminary results on the preparation of Spanish Broom, flax and hemp wound dressings based on 18-β-glycyrrhetinic acid-cyclodextrin inclusion complexes 116
Orally administered vaginal Bifidobacterium Breve BC104 for preventing genital and urinary tract infections 111
A new wound dressing based on Spanish Broom fibers for the local release of Vitamin E and Lactobacillus plantarum 111
Development of chitosan nanoparticles with mucoadhesive/mucopenetrating properties 111
Vaginal lactobacilli exert prebioTIc effects towards gut bifidobacteria 105
New liposomes containing natural molecules for treatment of vaginal diseases 105
Human Lactobacillus Biosurfactants as Natural Excipients for Nasal Drug Delivery of Hydrocortisone 105
Freeze-dried matrices for chlorhexidine release in the buccal and vaginal cavities 102
Exopolysaccharides released by vaginal Lactobacillus strains: chemical characterization and modulation of biofilm formation. 99
null 96
null 94
Impact of Lactobacillus exopolysaccharides on vaginal microbial biofilms 92
Lactobacillus biosurfactant as natural excipient for nasal drug delivery 92
New Spanish Broom’s wound dressing loaded with Vitamin E and Lactobacillus plantarum for skin wounds 91
Lactobacillus biosurfactant: a green excipient for the preparation of vaginal mixed vesicles 88
Novel mixed vesicles containing lactobacilli biosurfactant for vaginal delivery of an anti-Candida agent 86
Sistemi gelificanti in situ per la veicolazione intranasale e naso-cervello di farmaci con diverse proprietà fisico-chimiche 85
Vaginal Lactobacilli interfere with Chlamydia trachomatis infection process in HeLa cells. 85
Candida spp. biofilm formation is inhibited by vaginal Lactobacillus supernatants 82
LACTOBACILLUS VAGINALIS BC17 DERIVATIVES EXERT BIFIDOGENIC ACTIVITY 77
Lactobacilli as Anti-biofilm Strategy in Oral Infectious Diseases: A Mini-Review 75
Functional and Safety Profile of Limosilactobacillus vaginalis and Development of Oral Fast-Disintegrating Tablets for Gut Microbiota Modulation 73
The vaginal microbiome of healthy, bacterial vaginosis and Chlamydia trachomatis-infected women 71
Tailored anti-biofilm activity - Liposomal delivery for mimic of small antimicrobial peptide 70
Liposomes-in-chitosan hydrogel boosts potential of chlorhexidine in biofilm eradication in vitro 68
Nanocarriers for the delivery of Lactobacillus crispatus BC1 biosurfactant: alternative strategies to fight Candida biofilms 56
null 47
Biotechnological valorization of brewer's spent grains through microbial fermentation and High-Pressure Homogenization (HPH) treatments to obtain functional ingredients for food formulations 37
Microbial fermentation and high-pressure homogenization as integrated strategies for the valorization of brewer’s spent grains into functional food ingredients 32
Totale 13.092
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.987
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021386 0 0 0 0 0 0 0 0 0 77 44 265
2021/20221.022 83 57 55 27 103 57 39 75 46 82 215 183
2022/20231.483 137 185 79 177 111 106 29 87 256 104 105 107
2023/2024911 57 73 64 98 92 174 60 72 42 64 59 56
2024/20252.543 122 228 237 186 318 120 316 146 62 164 193 451
2025/20264.993 429 595 527 430 474 257 817 184 887 393 0 0
Totale 13.092